Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK1 | P19367 | 3/20 | 0.47 |
| ▸ | HK2 | P52789 | 3/20 | 0.47 |
| ▸ | TYMP | P19971 | 9/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HRAS | P01112 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17435236 | 1.00 | HK1 (0.47) | HK1HK2TYMPMAPK1HRAS | |
| SCHEMBL12812836 | 0.83 | HK1 (0.43) | HK1HK2TYMP | |
| SCHEMBL12812835 | 0.83 | HK1 (0.43) | HK1HK2TYMP | |
| SCHEMBL7235905 | 0.82 | TYMP (0.45) | TYMPMAPK1 | |
| SCHEMBL7235898 | 0.82 | TYMP (0.45) | TYMPMAPK1 | |
| SCHEMBL7774713 | 0.82 | TP53 (0.47) | TYMPMAPK1HRAS | |
| SCHEMBL23113802 | 0.80 | TYMP (0.49) | HK1HK2TYMP | |
| SCHEMBL3194070 | 0.80 | TYMP (0.49) | HK1HK2TYMP | |
| SCHEMBL3194078 | 0.80 | TYMP (0.49) | HK1HK2TYMP | |
| SCHEMBL8023003 | 0.80 | LMNA (0.52) | TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540219-B2 | Method for deacetylation of biopolymers | Galderma Holding SA (CH) | 2026-02-03 | — | — | US | disclosed |
| US-12365768-B2 | Method for deacetylation of biopolymers | Galderma Holding SA (CH) | 2025-07-22 | — | — | US | disclosed |
| EP-3397650-B1 | HYDROLYSIS OF ESTER BONDS IN AMIDE CROSSLINKED GLYCOSAMINOGLYCANS | GALDERMA SA (CH) | 2025-05-14 | — | — | EP | disclosed |
| US-20240199822-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | Galderma Holding SA (CH) | 2024-06-20 | — | — | US | disclosed |
| US-11939433-B2 | Method for preparing acylated crosslinked glycosaminoglycans | GALDERMA HOLDING S.A. (CH) | 2024-03-26 | — | — | US | disclosed |
| US-20230323041-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | Galderma Holding SA (CH) | 2023-10-12 | — | — | US | disclosed |
| US-11708461-B2 | Method for preparing acylated crosslinked glycosaminoglycans | Galderma Holding SA (CH) | 2023-07-25 | — | — | US | disclosed |
| CN-116284867-A | Method for deacetylation of biopolymers | 高德美控股有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-108779184-B | Method for deacetylation of biopolymers | 高德美控股有限公司 | 2023-04-21 | — | — | CN | disclosed |
| US-20220177655-A1 | METHOD FOR DEACETYLATION OF BIOPOLYMERS | Galderma Holding SA (CH) | 2022-06-09 | — | — | US | disclosed |
| US-11066526-B2 | Method for cleaving amide bonds | Galderma Holding SA (CH) | 2021-07-20 | — | — | US | disclosed |
| US-20210108036-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | GALDERMA S.A. (CH) | 2021-04-15 | — | — | US | disclosed |
| US-10954316-B2 | Method for cleaving amide bonds | Galderma Holding SA (CH) | 2021-03-23 | — | — | US | disclosed |
| US-10899894-B2 | Method for preparing acylated crosslinked glycosaminoglycans | GALDERMA S.A (CH) | 2021-01-26 | — | — | US | disclosed |
| EP-3397648-B1 | METHOD FOR DEACETYLATION OF BIOPOLYMERS | GALDERMA SA (CH) | 2020-05-27 | — | — | EP | disclosed |
| EP-3397649-B1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | GALDERMA SA (CH) | 2020-05-27 | — | — | EP | disclosed |
| US-20200030219-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | GALDERMA S.A. (CH) | 2020-01-30 | — | — | US | disclosed |
| US-20190023855-A1 | HYDROLYSIS OF ESTER BONDS IN AMIDE CROSSLINKED GLYCOSAMINOGLYCANS | GALDERMA S.A. (CH) | 2019-01-24 | — | — | US | disclosed |
| US-20190016830-A1 | METHOD FOR DEACETYLATION OF BIOPOLYMERS | GALDERMA S.A. (CH) | 2019-01-17 | — | — | US | disclosed |
| US-20190010113-A1 | METHOD FOR CLEAVING AMIDE BONDS | GALDERMA S.A. (CH) | 2019-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939433-B2 | Method for preparing acylated crosslinked glycosaminoglycans | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-20240199822-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-12540219-B2 | Method for deacetylation of biopolymers | CA12, CA13, CA1 | HK1 578/4885HK2 254/4885TYMP 2895/4885 |
| US-11708461-B2 | Method for preparing acylated crosslinked glycosaminoglycans | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-20230323041-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-20200030219-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-20190023855-A1 | HYDROLYSIS OF ESTER BONDS IN AMIDE CROSSLINKED GLYCOSAMINOGLYCANS | AMDHD2, HPSE, ENGASE | HK1 1630/4885HK2 1215/4885TYMP 2108/4885 |
| US-20210108036-A1 | METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
| US-20190010113-A1 | METHOD FOR CLEAVING AMIDE BONDS | DNPEP, NAAA, ASPH | HK1 3626/4885HK2 3184/4885TYMP 2440/4885 |
| US-11066526-B2 | Method for cleaving amide bonds | DNPEP, NAAA, ASPH | HK1 3626/4885HK2 3184/4885TYMP 2440/4885 |
| US-20220177655-A1 | METHOD FOR DEACETYLATION OF BIOPOLYMERS | AADAC, ALG1, AMDHD2 | HK1 1555/4885HK2 1119/4885TYMP 2899/4885 |
| US-12365768-B2 | Method for deacetylation of biopolymers | AADAC, ALG1, AMDHD2 | HK1 1555/4885HK2 1119/4885TYMP 2899/4885 |
| US-10899894-B2 | Method for preparing acylated crosslinked glycosaminoglycans | ALG1, CSGALNACT1, AMDHD2 | HK1 2335/4885HK2 1634/4885TYMP 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.